|
GOLPH3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098380E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.000850E-04 |
| Normal-vs-Stage2 |
2.543800E-01 |
| Normal-vs-Stage3 |
5.628200E-01 |
| Normal-vs-Stage4 |
9.213600E-01 |
| Stage1-vs-Stage2 |
2.099600E-01 |
| Stage1-vs-Stage3 |
2.711500E-02 |
| Stage1-vs-Stage4 |
6.937600E-02 |
| Stage2-vs-Stage3 |
2.274200E-01 |
| Stage2-vs-Stage4 |
4.463000E-01 |
| Stage3-vs-Stage4 |
7.879400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.305910E-02 |
| Normal-vs-AfricanAmerican |
1.244280E-02 |
| Normal-vs-Asian |
9.028600E-01 |
| Caucasian-vs-AfricanAmerican |
6.974400E-01 |
| Caucasian-vs-Asian |
4.119400E-01 |
| AfricanAmerican-vs-Asian |
2.518600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.301940E-03 |
| Normal-vs-Female |
9.272000E-01 |
| Male-vs-Female |
7.357800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.212300E-02 |
| Normal-vs-Extreme_Weight |
6.11609999999763E-05 |
| Normal-vs-Obese |
2.489200E-01 |
| Normal-vs-Extreme_Obese |
2.298800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.986600E-01 |
| Normal_Weight-vs-Obese |
2.857400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.623600E-01 |
| Extreme_Weight-vs-Obese |
1.295640E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.553000E-01 |
| Obese-vs-Extreme_Obese |
1.111620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.147400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.806400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.156200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.837900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.925600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.302800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.846400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.223600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.598200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.219250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.193700E-04 |
| Normal-VS-Type2 PRCC |
7.375000E-01 |
| Normal-VS-KIRP CIMP |
5.225000E-01 |
| Normal-VS-Unclassified PRCC |
3.172400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.294320E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.749700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.295610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.775400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.675000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.433400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.206460E-02 |
| Normal-vs-N1 |
1.267820E-01 |
| Normal-vs-N2 |
2.925200E-01 |
| N0-vs-N1 |
1.570450E-02 |
| N0-vs-N2 |
8.354800E-01 |
| N1-vs-N2 |
3.372200E-01 |
|
|
